OrbiMed Capital GP V LLC (CIK 0001615374)

Latest company ownership

Shares held
5,193,946
Last filed at
Dec 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
4,975,291
Last filed at
Oct 27, 2025
Confidence Score
20.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
4,901,310
Last filed at
Jun 6, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
3,571,428
Last filed at
Nov 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ACET - Adicet Bio, Inc.
Role: 10% Owner
Shares held
2,930,527
Last filed at
Oct 10, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2023Q2 2025Q4
Shares held
2,750,079
Last filed at
May 24, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
1,469,524
Last filed at
Feb 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
1,397,684
Last filed at
Jul 1, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
1,348,326
Last filed at
Nov 29, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
564,780
Last filed at
May 13, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
SIBN - SI-BONE, Inc.
Role: Director
Shares held
179,404
Last filed at
Oct 19, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 23, 2025 Oct 27, 2025 PMV Pharmaceuticals, Inc. 10% Owner Sell 17.5 -1,000,000 -16.74% ✗ $1.5M
Oct 8, 2025 Oct 10, 2025 Adicet Bio, Inc. 10% Owner Buy 100.0 +5,000,000 58.71% ✗ $5M
Sep 10, 2025 Sep 12, 2025 PMV Pharmaceuticals, Inc. 10% Owner Sell 20.0 -500,000 -7.72% ✗ $900K
Jun 27, 2025 Jul 1, 2025 Corvus Pharmaceuticals, Inc. Director Sell 17.5 -1,176,332 -14.10% ✗ $4.9M
Jan 25, 2024 Jan 26, 2024 Adicet Bio, Inc. Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Nov 22, 2023 Nov 24, 2023 PMV Pharmaceuticals, Inc. 10% Owner Sell 22.5 -87,786 -100.00% ✗ $195.8K
Jun 27, 2023 Jun 29, 2023 Adicet Bio, Inc. Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Nov 8, 2022 Nov 10, 2022 Compass Therapeutics, Inc. Director Buy 92.5 +402,000 2.71% ✗ $1.3M
May 26, 2022 May 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 20.0 -26,253 -23.02% ✗ $418.2K
May 11, 2022 May 13, 2022 Compass Therapeutics, Inc. Director Buy 85.0 +192,516 1.32% ✗ $420.5K
May 6, 2022 May 10, 2022 Compass Therapeutics, Inc. Director Buy 72.5 +125,359 0.86% ✗ $197.3K
Mar 29, 2022 Mar 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 15.0 -474,500 -100.00% ✗ $10.3M
Nov 4, 2021 Nov 8, 2021 Compass Therapeutics, Inc. Director Buy 100.0 +5,357,143 42.13% ✗ $18.8M
Sep 20, 2021 Sep 22, 2021 Corvus Pharmaceuticals, Inc. Director Sell 16.3 -1,109,644 -13.78% ✗ $6.8M
Feb 17, 2021 Feb 19, 2021 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +1,285,714 19.00% ✗ $4.5M
Dec 8, 2020 Dec 10, 2020 Whitehawk Therapeutics, Inc. 10% Owner Sell 26.3 -21,400 -100.00% ✗ $41.9K
Sep 25, 2020 Sep 29, 2020 PMV Pharmaceuticals, Inc. Director Buy 100.0 +950,000 100.00% ✗ $17.1M
Aug 17, 2020 Aug 19, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -138,443 -100.00% ✗ $14.9M
Aug 12, 2020 Aug 14, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -92,187 -15.98% ✗ $10M
Aug 7, 2020 Aug 11, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -116,570 -33.59% ✗ $12.3M
Jun 19, 2020 Jun 23, 2020 Compass Therapeutics, Inc. Director Buy 100.0 +1,455,132 12.92% ✗ $7.3M
Mar 6, 2020 Mar 10, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -500,000 -59.03% ✗ $41.8M
Mar 3, 2020 Mar 5, 2020 Inspire Medical Systems, Inc. Director Sell 15.0 -500,000 -37.12% ✗ $42.1M
Nov 26, 2019 Nov 29, 2019 Inspire Medical Systems, Inc. Director Sell 22.5 -124,000 -8.42% ✓ $8.8M
Aug 6, 2019 Aug 8, 2019 Corvus Pharmaceuticals, Inc. Director Buy 85.0 +142,656 2.15% ✗ $500.7K
Jun 27, 2019 Jul 1, 2019 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +657,344 11.02% ✗ $2.4M
Mar 7, 2019 Mar 11, 2019 Inspire Medical Systems, Inc. Director Sell 15.0 -358,449 -19.59% ✗ $20.5M
Dec 11, 2018 Dec 13, 2018 Inspire Medical Systems, Inc. Director Sell 15.0 -614,772 -100.00% ✗ $23.1M
Oct 19, 2018 Oct 19, 2018 SI-BONE, Inc. Director Buy 100.0 +200,000 25.47% ✗ $3M
Jun 28, 2018 Jul 2, 2018 Whitehawk Therapeutics, Inc. Director Buy 100.0 +777,500 17.60% ✗ $3M
Jun 4, 2018 Jun 6, 2018 Adaptimmune Therapeutics PLC Director Sell 37.5 -18,700 -0.38% ✗ $253.6K
May 30, 2018 Jun 1, 2018 Adaptimmune Therapeutics PLC Director Sell 17.5 -171,000 -3.36% ✗ $2.3M
May 22, 2018 May 24, 2018 RHYTHM PHARMACEUTICALS, INC. 10% Owner Sell 30.0 -19,580 -0.71% ✗ $595.8K
May 18, 2018 May 21, 2018 RHYTHM PHARMACEUTICALS, INC. 10% Owner Sell 17.5 -131,636 -4.54% ✗ $4.1M
May 14, 2018 May 16, 2018 Adaptimmune Therapeutics PLC Director Sell 40.0 -10,300 -0.20% ✗ $139.1K
May 7, 2018 May 9, 2018 Inspire Medical Systems, Inc. 10% Owner Buy 100.0 +312,500 14.66% ✗ $5M
Mar 27, 2018 Mar 29, 2018 Adaptimmune Therapeutics PLC Director Sell 15.0 -1,048,067 -17.04% ✗ $12.1M
Mar 12, 2018 Mar 14, 2018 Corvus Pharmaceuticals, Inc. Director Buy 100.0 +588,235 10.94% ✗ $5M
Oct 10, 2017 Oct 10, 2017 RHYTHM PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +355,000 13.94% ✗ $6M
Mar 27, 2017 Mar 28, 2017 Adaptimmune Therapeutics PLC Director Buy 100.0 +1,190,476 24.01% ✗ $5M
Mar 15, 2017 Mar 17, 2017 Whitehawk Therapeutics, Inc. Director Buy 100.0 +762,995 20.88% ✗ $3.8M
Feb 16, 2017 Feb 21, 2017 Spyre Therapeutics, Inc. 10% Owner Buy 92.5 +109,300 8.04% ✗ $563.9K
Jun 23, 2016 Jun 27, 2016 Corvus Pharmaceuticals, Inc. Director Buy 48.8 +1,000 0.02% ✗ $13K
Jun 17, 2016 Jun 21, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +38,383 0.72% ✗ $489.2K
Jun 14, 2016 Jun 16, 2016 Corvus Pharmaceuticals, Inc. Director Buy 65.0 +20,000 0.38% ✗ $247K
Jun 9, 2016 Jun 13, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +50,000 0.95% ✗ $648.1K
May 20, 2016 May 25, 2016 Adaptimmune Therapeutics PLC Director Buy 97.5 +1,712,400 6.11% ✗ $17.8M
May 20, 2016 May 24, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +4,716 0.09% ✗ $61.7K
May 18, 2016 May 20, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +6,800 0.13% ✗ $80K
May 11, 2016 May 13, 2016 Intellia Therapeutics, Inc. Director Buy 100.0 +250,000 10.36% ✗ $4.5M